Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$5.48 - $9.86 $3,567 - $6,418
-651 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$13.28 - $18.07 $39,999 - $54,426
-3,012 Reduced 82.23%
651 $9,000
Q4 2020

Feb 11, 2021

BUY
$16.84 - $27.59 $50,722 - $83,101
3,012 Added 462.67%
3,663 $97,000
Q2 2020

Aug 13, 2020

BUY
$5.24 - $23.4 $3,411 - $15,233
651 New
651 $15,000
Q1 2020

May 13, 2020

SELL
$4.41 - $9.28 $2,875 - $6,050
-652 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$1.45 - $6.73 $945 - $4,387
652 New
652 $4,000

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $59.3M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.